Table 4.
Clinical situations where the cure probability was >26% (75th percentile).
| Clinical features | Cure prob. (95% C.I.) | Years of life lost (95% C.I.) | |||||
|---|---|---|---|---|---|---|---|
| Gender | Hepatitis C | Tumour burden | ALBI | All patients | Age < 60 years | Age 60–70 years | Age > 70 years |
| Female | Negative | Single <2 cm | 1 | 39.8% (31.3, 48.3) | 19.5 (18.0, 21.1) | 13.0 (11.4, 14.5) | 6.5 (5.0, 8.0) |
| Female | Negative | Single 2–3 cm | 1 | 35.7% (27.2, 44.3) | 20.3 (18.7, 21.8) | 13.7 (12.2, 15.2) | 7.2 (5.7, 8.7) |
| Male | Negative | Single <2 cm | 1 | 33.8% (25.3, 42.4) | 17.8 (16.2, 19.3) | 11.2 (9.7, 12.8) | 4.7 (3.2, 6.2) |
| Female | Positive | Single <2 cm | 1 | 32.3% (24.0, 40.9) | 21.0 (19.5, 22.6) | 14.5 (13.0, 16.0) | 8.0 (6.4, 9.5) |
| Female | Negative | Single <2 cm | 2 | 32.1% (23.8, 40.7) | 21.3 (19.7, 22.8) | 14.8 (13.2, 16.3) | 8.2 (6.7, 9.7) |
| Male | Negative | Single 2–3 cm | 1 | 29.6% (21.5, 38.2) | 18.5 (17.0, 20.0) | 12.0 (10.4, 13.5) | 5.4 (3.9, 6.9) |
| Female | Negative | 2-3 nodules <2 cm | 1 | 28.9% (20.8, 37.4) | 21.3 (19.7, 22.8) | 14.7 (13.2, 16.3) | 8.3 (6.7, 9.7) |
| Female | Positive | Single 2–3 cm | 1 | 28.1% (20.2, 36.7) | 21.7 (20.2, 23.3) | 15.2 (13.7, 16.7) | 8.7 (7.1, 10.2) |
| Male | Positive | Single <2 cm | 1 | 26.3% (18.5, 34.8) | 19.3 (17.7, 20.8) | 12.7 (11.2, 14.2) | 6.2 (4.7, 7.7) |
Estimates consider that clinical features not included were at their mean and that patients were treated from 2014 onward.